TY - JOUR
T1 - Racial/ethnic differences in inpatient palliative care consultation for patients with advanced cancer
AU - Sharma, Rashmi K.
AU - Cameron, Kenzie A.
AU - Chmiel, Joan S.
AU - Von Roenn, Jamie H.
AU - Szmuilowicz, Eytan
AU - Prigerson, Holly G.
AU - Penedo, Frank J.
N1 - Publisher Copyright:
© 2015 by American Society of Clinical Oncology.
PY - 2015/11/10
Y1 - 2015/11/10
N2 - Purpose: Inpatient palliative care consultation (IPCC) may help address barriers that limit the use of hospice and the receipt of symptom-focused care for racial/ethnic minorities, yet little is known about disparities in the rates of IPCC. We evaluated the association between race/ethnicity and rates of PCC for patients with advanced cancer. Patients and Methods: Patients with metastatic cancer who were hospitalized between January 1, 2009, and December 31, 2010, at an urban academic medical center participated in the study. Patient-level multivariable logistic regression was used to evaluate the association between race/ethnicity and IPCC Results: A total of 6,288 patients (69% non-Hispanic white, 19% African American, and 6% Hispanic) were eligible. Of these patients, 16% of whites, 22% of African Americans, and 20% of Hispanics had an IPCC (overall P <.001). Compared with whites, African Americans had a greater likelihood of receiving an IPCC (odds ratio, 1.21; 95% CI, 1.01 to 1.44), even after adjusting for insurance, hospitalizations, marital status, and illness severity. Among patients who received an IPCC, African Americans had a higher median number of days from IPCC to death compared with whites (25 v 17 days; P =.006), and were more likely than Hispanics (59% v41%; P =.006), but not whites, to be referred to hospice Conclusion: Inpatient settings may neutralize some racial/ethnic differences in access to hospice and palliative care services; however, irrespective of race/ethnicity, rates of IPCC remain low and occur close to death. Additional research is needed to identify interventions to improve access to palliative care in the hospital for all patients with advanced cancer.
AB - Purpose: Inpatient palliative care consultation (IPCC) may help address barriers that limit the use of hospice and the receipt of symptom-focused care for racial/ethnic minorities, yet little is known about disparities in the rates of IPCC. We evaluated the association between race/ethnicity and rates of PCC for patients with advanced cancer. Patients and Methods: Patients with metastatic cancer who were hospitalized between January 1, 2009, and December 31, 2010, at an urban academic medical center participated in the study. Patient-level multivariable logistic regression was used to evaluate the association between race/ethnicity and IPCC Results: A total of 6,288 patients (69% non-Hispanic white, 19% African American, and 6% Hispanic) were eligible. Of these patients, 16% of whites, 22% of African Americans, and 20% of Hispanics had an IPCC (overall P <.001). Compared with whites, African Americans had a greater likelihood of receiving an IPCC (odds ratio, 1.21; 95% CI, 1.01 to 1.44), even after adjusting for insurance, hospitalizations, marital status, and illness severity. Among patients who received an IPCC, African Americans had a higher median number of days from IPCC to death compared with whites (25 v 17 days; P =.006), and were more likely than Hispanics (59% v41%; P =.006), but not whites, to be referred to hospice Conclusion: Inpatient settings may neutralize some racial/ethnic differences in access to hospice and palliative care services; however, irrespective of race/ethnicity, rates of IPCC remain low and occur close to death. Additional research is needed to identify interventions to improve access to palliative care in the hospital for all patients with advanced cancer.
UR - http://www.scopus.com/inward/record.url?scp=84947444058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84947444058&partnerID=8YFLogxK
U2 - 10.1200/JCO.2015.61.6458
DO - 10.1200/JCO.2015.61.6458
M3 - Article
C2 - 26324373
AN - SCOPUS:84947444058
SN - 0732-183X
VL - 33
SP - 3802
EP - 3808
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 32
ER -